Asthma Comparative Effectiveness Study
NCT01623544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6086
Last updated 2013-02-25
Summary
The objective of this study is to compare the real-world effectiveness of BFC and FSC in asthma patients new to ICS/LABA combination therapy in a population of U.S. health plan enrollees.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2012-07-31
- Completion
- 2012-09-30
More Related Trials
-
Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma
NCT00830505 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
NCT02139644 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01159912 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
NCT02141854 ·Status: COMPLETED ·Phase: PHASE3
-
Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma
NCT01070524 ·Status: COMPLETED ·Phase: PHASE2
-
Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand
NCT00800241 ·Status: COMPLETED
-
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
NCT01431950 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma
NCT01687283 ·Status: COMPLETED ·Phase: PHASE3
-
Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management
NCT01908075 ·Status: COMPLETED
-
Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma
NCT00862264 ·Status: COMPLETED ·Phase: PHASE3
-
Utilization of Fixed Combination (Budesonide/Formoterol and Salmeterol/Fluticasone and Beclomethasone/Formoterol) in Treatment of Asthma Patients
NCT01327001 ·Status: COMPLETED
-
A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
NCT05755906 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Patients With Asthma
NCT00215358 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
NCT05292586 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
NCT02105012 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients
NCT05152355 ·Status: COMPLETED ·Phase: PHASE4
-
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
NCT00393952 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients
NCT02934945 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
NCT00843193 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Patients With Asthma
NCT00215410 ·Status: COMPLETED ·Phase: PHASE2
-
A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)
NCT05202262 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
NCT03756883 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma
NCT02725242 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy
NCT02181335 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
NCT00497237 ·Status: COMPLETED ·Phase: PHASE3